Show simple item record

dc.contributor.authorEfrata, Tommy C
dc.date.accessioned2014-02-13T02:14:15Z
dc.date.available2014-02-13T02:14:15Z
dc.date.issued2009-08-08
dc.identifier.citationEfrata, T. C. (2009). Informasi asimetris, intensitas riset dan pengembangan dan terjadinya underpricing pada saat penawaran saham perdana. In Proceeding Konferensi Nasional I "Dampak Country Risk Terhadap Perusahaan Ditinjau dari Aspek Manajemen & Akuntansi" (pp. 021-037). Retrieved from http://dspace.uc.ac.id/handle/123456789/345
dc.identifier.urihttp://dspace.uc.ac.id/handle/123456789/345
dc.description.abstractAsymmetric information between firm's insiders and investors is believed by many financial scholars as the main cause of the underpricing phenomenon during initial public offering (IPO). For the firms within pharmaceutical and biotechnology industries the sources of asymmetric information may come from research and development activities. Using 82 IPO firms in the US, this paper documents a strong association (negative) between IPO initial underpricing and the R&D intensity for the firms in the sectors. The finding of this study suggests that R&D is the main contributor 10 the asymmetric information.en_US
dc.publisherProceeding Konferensi Nasional I – 8 Agustus 2009 – ISBN: 978-602-95291-0-4 – PSEB Fakultas Ekonomi Universitas Kristen Duta Wacanaen_US
dc.subjectInformasi Asimetris, Underpricing, Intensitas Riset Dan Pengembangan, Farmasi Dan Bioteknologien_US
dc.titleInformasi Asimetris, Intensitas Riset Dan Pengembangan Dan Terjadinya Underpricing Pada Saat Penawaran Saham Perdanaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record